PMC:7558914 / 756-930 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7558914","sourcedb":"PMC","sourceid":"7558914","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7558914","text":"tors (33.3%). Combined hydroxychloroquine with azithromycin or lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderat","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"39","span":{"begin":144,"end":152},"obj":"Species"},{"id":"44","span":{"begin":23,"end":41},"obj":"Chemical"},{"id":"45","span":{"begin":47,"end":59},"obj":"Chemical"},{"id":"46","span":{"begin":63,"end":82},"obj":"Chemical"}],"attributes":[{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D006886"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D017963"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C558899"},{"subj":"39","pred":"source","obj":"LitCovid-PubTator"},{"subj":"44","pred":"source","obj":"LitCovid-PubTator"},{"subj":"45","pred":"source","obj":"LitCovid-PubTator"},{"subj":"46","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":14,"end":113},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T8","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#94ec93","default":true},{"id":"LitCovid-sentences","color":"#ec93ae"}]}]}}